{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:07:06Z","timestamp":1790737626503,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The &amp;#x00C5;land cultural foundation"},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["654241"],"award-info":[{"award-number":["654241"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"EC | Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"name":"&amp;#x00C5;ke Wiberg Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Huntington\u2019s disease (HD) is a severe neurological disease leading to psychiatric symptoms, motor impairment and cognitive decline. The disease is caused by a CAG expansion in the huntingtin (HTT) gene, but how this translates into the clinical phenotype of HD remains elusive. Using liquid chromatography mass spectrometry, we analyzed the metabolome of cerebrospinal fluid (CSF)\u00a0from premanifest and manifest HD subjects as well as control subjects. Inter-group differences revealed that the tyrosine metabolism, including tyrosine, thyroxine, L-DOPA and dopamine, was significantly altered in manifest compared with premanifest HD. These metabolites demonstrated moderate to strong associations to measures of disease severity and symptoms. Thyroxine and dopamine also correlated with the five year risk of onset in premanifest HD subjects. The phenylalanine and the purine metabolisms were also significantly altered, but associated less to disease severity. Decreased levels of lumichrome were commonly found in mutated HTT carriers and the levels correlated with the five year risk of disease onset in premanifest carriers. These biochemical findings demonstrates that the CSF metabolome can be used to characterize molecular pathogenesis occurring in HD, which may be essential for future development of novel HD therapies.<\/jats:p>","DOI":"10.1038\/s41598-019-40186-5","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T07:03:05Z","timestamp":1552287785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington\u2019s disease subjects"],"prefix":"10.1038","volume":"9","author":[{"given":"Stephanie","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Emami Khoonsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Sundblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-1806","authenticated-orcid":false,"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Landtblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Spjuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Nyholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"40186_CR1","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72, 971\u2013983 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"40186_CR2","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/nature06909","volume":"453","author":"L-B Li","year":"2008","unstructured":"Li, L.-B., Yu, Z., Teng, X. & Bonini, N. M. RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 1107\u20131111 (2008).","journal-title":"Nature"},{"key":"40186_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun, I. V. et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447, 447\u2013452 (2007).","journal-title":"Nature"},{"key":"40186_CR4","doi-asserted-by":"publisher","first-page":"e1002018","DOI":"10.1371\/journal.pgen.1002018","volume":"7","author":"CE Pearson","year":"2011","unstructured":"Pearson, C. E. Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities! PLoS Genet. 7, e1002018 (2011).","journal-title":"PLoS Genet."},{"key":"40186_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C. A. et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10, 204\u2013216 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"40186_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The Biology of Huntingtin. Neuron 89, 910\u2013926 (2016).","journal-title":"Neuron"},{"key":"40186_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S0317167100012671","volume":"39","author":"C Rinaldi","year":"2012","unstructured":"Rinaldi, C. et al. Predictors of survival in a Huntington\u2019s disease population from southern Italy. Can. J. Neurol. Sci. 39, 48\u201351 (2012).","journal-title":"Can. J. Neurol. Sci."},{"key":"40186_CR8","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.7150\/thno.26249","volume":"8","author":"S Herman","year":"2018","unstructured":"Herman, S. et al. Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis. Theranostics 8, 4477\u20134490 (2018).","journal-title":"Theranostics"},{"key":"40186_CR9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.bbadis.2011.08.001","volume":"1812","author":"KA Verwaest","year":"2011","unstructured":"Verwaest, K. A. et al. (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. Biochim. Biophys. Acta 1812, 1371\u20131379 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"40186_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","volume":"31","author":"M-L Cheng","year":"2016","unstructured":"Cheng, M.-L., Chang, K.-H., Wu, Y.-R. & Chen, C.-M. Metabolic disturbances in plasma as biomarkers for Huntington\u2019s disease. J. Nutr. Biochem. 31, 38\u201344 (2016).","journal-title":"J. Nutr. Biochem."},{"key":"40186_CR11","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.bbadis.2018.04.012","volume":"1864","author":"SF Graham","year":"2018","unstructured":"Graham, S. F. et al. Targeted biochemical profiling of brain from Huntington\u2019s disease patients reveals novel metabolic pathways of interest. Biochim. Biophys. Acta 1864, 2430\u20132437 (2018).","journal-title":"Biochim. Biophys. Acta"},{"key":"40186_CR12","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","volume":"1862","author":"SF Graham","year":"2016","unstructured":"Graham, S. F. et al. Metabolic signatures of Huntington\u2019s disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain. Biochim. Biophys. Acta 1862, 1675\u20131684 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"40186_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1074\/mcp.M800231-MCP200","volume":"8","author":"Q Fang","year":"2009","unstructured":"Fang, Q. et al. Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease. Mol. Cell. Proteomics 8, 451\u2013466 (2009).","journal-title":"Mol. Cell. Proteomics"},{"key":"40186_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mds.26011","volume":"29","author":"R Reilmann","year":"2014","unstructured":"Reilmann, R., Leavitt, B. R. & Ross, C. A. Diagnostic criteria for Huntington\u2019s disease based on natural history. Mov. Disord. 29, 1335\u20131341 (2014).","journal-title":"Mov. Disord."},{"key":"40186_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson, I. & Fahn, S. Huntington disease: clinical care and evaluation. Neurology 29, 1\u20133 (1979).","journal-title":"Neurology"},{"key":"40186_CR16","doi-asserted-by":"crossref","unstructured":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov. Disord. 11, 136\u2013142 (1996).","DOI":"10.1002\/mds.870110204"},{"key":"40186_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn, D. R. et al. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin. Genet. 65, 267\u2013277 (2004).","journal-title":"Clin. Genet."},{"key":"40186_CR18","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen, C. E. et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73, 1914\u20131922 (2009).","journal-title":"Neurology"},{"key":"40186_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918\u2013920 (2012).","journal-title":"Nat. Biotechnol."},{"key":"40186_CR20","doi-asserted-by":"crossref","unstructured":"Berthold, M. R. et al. KNIME: The Konstanz Information Miner. In Studies in Classification, Data Analysis, and Knowledge Organization 319\u2013326 (2008).","DOI":"10.1007\/978-3-540-78246-9_38"},{"key":"40186_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1074\/mcp.M113.031278","volume":"13","author":"E Kenar","year":"2014","unstructured":"Kenar, E. et al. Automated label-free quantification of metabolites from liquid chromatography-mass spectrometry data. Mol. Cell. Proteomics 13, 348\u2013359 (2014).","journal-title":"Mol. Cell. Proteomics"},{"key":"40186_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1021\/pr300992u","volume":"12","author":"H Weisser","year":"2013","unstructured":"Weisser, H. et al. An automated pipeline for high-throughput label-free quantitative proteomics. J. Proteome Res. 12, 1628\u20131644 (2013).","journal-title":"J. Proteome Res."},{"key":"40186_CR23","unstructured":"Website. Available at: R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org. (Accessed: 28th March 2018)."},{"key":"40186_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-017-1213-z","volume":"13","author":"S Herman","year":"2017","unstructured":"Herman, S. et al. Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions. Metabolomics 13, 79 (2017).","journal-title":"Metabolomics"},{"key":"40186_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"40186_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10548-015-0455-1","volume":"29","author":"F Falahati","year":"2016","unstructured":"Falahati, F. et al. The Effect of Age Correction on Multivariate Classification in Alzheimer\u2019s Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects. Brain Topogr. 29, 296\u2013307 (2016).","journal-title":"Brain Topogr."},{"key":"40186_CR27","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart, F., Gautier, B., Singh, A. & Cao, K.-A. L. mixOmics: An R package for \u2018omics feature selection and multiple data integration. PLoS Comput. Biol. 13, e1005752 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"40186_CR28","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1021\/acs.jproteome.5b00354","volume":"14","author":"EA Th\u00e9venot","year":"2015","unstructured":"Th\u00e9venot, E. A., Roux, A., Xu, Y., Ezan, E. & Junot, C. Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses. J. Proteome Res. 14, 3322\u20133335 (2015).","journal-title":"J. Proteome Res."},{"key":"40186_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).","journal-title":"BMC Bioinformatics"},{"key":"40186_CR30","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0\u2013making metabolomics more meaningful. Nucleic Acids Res. 43, W251\u20137 (2015).","journal-title":"Nucleic Acids Res."},{"key":"40186_CR31","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1073\/pnas.1603023113","volume":"113","author":"R Chaleckis","year":"2016","unstructured":"Chaleckis, R., Murakami, I., Takada, J., Kondoh, H. & Yanagida, M. Individual variability in human blood metabolites identifies age-related differences. Proc. Natl. Acad. Sci. USA 113, 4252\u20134259 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"40186_CR32","doi-asserted-by":"publisher","first-page":"e0138848","DOI":"10.1371\/journal.pone.0138848","volume":"10","author":"E Kalliolia","year":"2015","unstructured":"Kalliolia, E. et al. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington\u2019s Disease. PLoS One 10, e0138848 (2015).","journal-title":"PLoS One"},{"key":"40186_CR33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2265.2010.03836.x","volume":"73","author":"NA Aziz","year":"2010","unstructured":"Aziz, N. A., Pijl, H., Fr\u00f6lich, M., Roelfsema, F. & Roos, R. A. C. Altered thyrotropic and lactotropic axes regulation in Huntington\u2019s disease. Clin. Endocrinol. 73, 540\u2013545 (2010).","journal-title":"Clin. Endocrinol."},{"key":"40186_CR34","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.psyneuen.2012.10.012","volume":"38","author":"P Johansson","year":"2013","unstructured":"Johansson, P. et al. Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer\u2019s disease. Psychoneuroendocrinology 38, 1058\u20131066 (2013).","journal-title":"Psychoneuroendocrinology"},{"key":"40186_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","volume":"20","author":"M Kori","year":"2016","unstructured":"Kori, M., Ayd\u0131n, B., Unal, S., Arga, K. Y. & Kazan, D. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Amyotrophic Lateral Sclerosis. OMICS 20, 645\u2013661 (2016).","journal-title":"OMICS"},{"key":"40186_CR36","first-page":"E185","volume":"245","author":"MB Dratman","year":"1983","unstructured":"Dratman, M. B., Crutchfield, F. L., Gordon, J. T. & Jennings, A. S. Iodothyronine homeostasis in rat brain during hypo- and hyperthyroidism. Am. J. Physiol. 245, E185\u201393 (1983).","journal-title":"Am. J. Physiol."},{"key":"40186_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jmg.2009.066399","volume":"46","author":"M Futter","year":"2009","unstructured":"Futter, M. et al. Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors. J. Med. Genet. 46, 438\u2013446 (2009).","journal-title":"J. Med. Genet."},{"key":"40186_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-160196","volume":"5","author":"LM Byrne","year":"2016","unstructured":"Byrne, L. M. & Wild, E. J. Cerebrospinal Fluid Biomarkers for Huntington\u2019s Disease. J. Huntingtons Dis. 5, 1\u201313 (2016).","journal-title":"J. Huntingtons Dis."},{"key":"40186_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00343834","volume":"231","author":"G Oepen","year":"1982","unstructured":"Oepen, G., Cramer, H., Bernasconi, R. & Martin, P. Huntington\u2019s disease - imbalance of free amino acids in the cerebrospinal fluid of patients and offspring at-risk. Arch. Psychiatr. Nervenkr. 231, 131\u2013140 (1982).","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"40186_CR40","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","volume":"2","author":"F Mochel","year":"2007","unstructured":"Mochel, F. et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2, e647 (2007).","journal-title":"PLoS One"},{"key":"40186_CR41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/brain\/awl027","volume":"129","author":"BR Underwood","year":"2006","unstructured":"Underwood, B. R. et al. Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain 129, 877\u2013886 (2006).","journal-title":"Brain"},{"key":"40186_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archneurol.2010.358","volume":"68","author":"F Mochel","year":"2011","unstructured":"Mochel, F., Benaich, S., Rabier, D. & Durr, A. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Arch. Neurol. 68, 265\u2013267 (2011).","journal-title":"Arch. Neurol."},{"key":"40186_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","volume":"17","author":"M Gianfriddo","year":"2004","unstructured":"Gianfriddo, M., Melani, A., Turchi, D., Giovannini, M. G. & Pedata, F. Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol. Dis. 17, 77\u201388 (2004).","journal-title":"Neurobiol. Dis."},{"key":"40186_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbi.2006.04.014","volume":"163","author":"F Depeint","year":"2006","unstructured":"Depeint, F., Bruce, W. R., Shangari, N., Mehta, R. & O\u2019Brien, P. J. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem. Biol. Interact. 163, 94\u2013112 (2006).","journal-title":"Chem. Biol. Interact."},{"key":"40186_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF00716270","volume":"1","author":"V Bonnefil","year":"1981","unstructured":"Bonnefil, V., Castiglione, C. M., Cawthon, R. M. & Breakefield, X. O. Effect of riboflavin on monoamine oxidase activity in cultured neuroblastoma cells. Cell. Mol. Neurobiol. 1, 351\u2013359 (1981).","journal-title":"Cell. Mol. Neurobiol."},{"key":"40186_CR46","first-page":"114","volume":"7","author":"JY Chen","year":"2013","unstructured":"Chen, J. Y., Wang, E. A., Cepeda, C. & Levine, M. S. Dopamine imbalance in Huntington\u2019s disease: a mechanism for the lack of behavioral flexibility. Front. Neurosci. 7, 114 (2013).","journal-title":"Front. Neurosci."},{"key":"40186_CR47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu, M. et al. Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann. Neurol. 39, 385\u2013389 (1996).","journal-title":"Ann. Neurol."},{"key":"40186_CR48","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan Jr.","year":"1985","unstructured":"Brennan, W. A. Jr., Bird, E. D. & Aprille, J. R. Regional mitochondrial respiratory activity in Huntington\u2019s disease brain. J. Neurochem. 44, 1948\u20131950 (1985).","journal-title":"J. Neurochem."},{"key":"40186_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","volume":"210","author":"AOG Goodman","year":"2008","unstructured":"Goodman, A. O. G. et al. The metabolic profile of early Huntington\u2019s disease\u2013a combined human and transgenic mouse study. Exp. Neurol. 210, 691\u2013698 (2008).","journal-title":"Exp. Neurol."},{"key":"40186_CR50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fphys.2015.00383","volume":"6","author":"MA Garc\u00eda-Campos","year":"2015","unstructured":"Garc\u00eda-Campos, M. A., Espinal-Enr\u00edquez, J. & Hern\u00e1ndez-Lemus, E. Pathway Analysis: State of the Art. Front. Physiol. 6, 383 (2015).","journal-title":"Front. Physiol."},{"key":"40186_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00439-007-0393-4","volume":"122","author":"L Arning","year":"2007","unstructured":"Arning, L. et al. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. Hum. Genet. 122, 175\u2013182 (2007).","journal-title":"Hum. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40186-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T13:48:05Z","timestamp":1721051285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40186-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["40186"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-40186-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4129"}}